Key facts
- It has raised $1.6M; the latest was Seed Round ($1.6M) in Dec 2025.
- Notable investors include Japanese Society of Anti-Aging Medicine, LINK-J, XPRIZE.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for TIME TRAVELER
- ·The full record, as it builds
Funding rounds
No funding rounds for TIME TRAVELER are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TIME TRAVELER
Operator of a biotechnology company intended to advance drug discovery and healthcare focused on preventing and treating diseases related to aging. The company offers a portfolio of cancer therapies, anti-aging pharmaceuticals, gene identification related to tumor development, and detailed analysis of genetic mechanisms, enabling medical researchers, pharmaceutical developers, and healthcare providers to develop effective treatments and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2024
- Website
- ttraveler.jp/
- Ownership
- Privately Held (backing)
TIME TRAVELER doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TIME TRAVELER shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TIME TRAVELER in its N-PORT filings yet. We sweep new filings monthly.